The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-benzyl-4-(3-(pyridin-4-ylmethyl)ureido)benzenesulfonamide ID: ALA4877035
PubChem CID: 68248942
Max Phase: Preclinical
Molecular Formula: C20H20N4O3S
Molecular Weight: 396.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1ccncc1)Nc1ccc(S(=O)(=O)NCc2ccccc2)cc1
Standard InChI: InChI=1S/C20H20N4O3S/c25-20(22-14-17-10-12-21-13-11-17)24-18-6-8-19(9-7-18)28(26,27)23-15-16-4-2-1-3-5-16/h1-13,23H,14-15H2,(H2,22,24,25)
Standard InChI Key: WJODKZZQLZOOIT-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
17.4885 -9.0767 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3645 -7.9614 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7772 -8.6713 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.1856 -7.9589 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7141 -10.3304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7129 -11.1500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4210 -11.5589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1306 -11.1495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1278 -10.3268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4192 -9.9216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8340 -9.9156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5432 -10.3215 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2494 -9.9102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9586 -10.3161 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6648 -9.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2463 -9.0930 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.3700 -10.3126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0757 -9.9020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0731 -9.0839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3589 -8.6782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6561 -9.0911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1939 -8.6642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9039 -9.0688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9045 -9.8858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6136 -10.2904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3200 -9.8778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3128 -9.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6031 -8.6555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 2 2 0
4 3 2 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
9 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
13 16 2 0
15 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 15 1 0
19 3 1 0
3 1 1 0
1 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 396.47Molecular Weight (Monoisotopic): 396.1256AlogP: 2.88#Rotatable Bonds: 7Polar Surface Area: 100.19Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.18CX Basic pKa: 5.02CX LogP: 2.16CX LogD: 2.16Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.57Np Likeness Score: -1.76
References 1. Pinkerton AB, Sessions EH, Hershberger P, Maloney PR, Peddibhotla S, Hopf M, Sergienko E, Ma CT, Smith LH, Jackson MR, Tanaka J, Tsuji T, Akiu M, Cohen SE, Nakamura T, Gardell SJ.. (2021) Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators., 41 [PMID:33798699 ] [10.1016/j.bmcl.2021.128007 ]